Literature DB >> 18521262

Hypercalcemia caused by metastatic adamantinoma: response to radiotherapy.

J A Lyons1, G T Budd, R L Crownover.   

Abstract

Purpose. To describe successful palliation of a patient with metastatic adamantinoma presenting with lung metastases and hypercalcemia resulting from a parathormone-like substance released from the tumor.Methods and materials. The records of a patient with a history of a tibial adamantinoma who presented with symptoms of hypercalcemia 20 years after the original surgery, as well as the literature concerning hypercalcemia and adamantinoma were reviewed and summarized.Results. After thorough review of the literature we found no prior reports of radiation being used for palliation of hypercalcemia associated with metastatic adamantinoma.We report rapid improvement in symptoms and normalization of serum calcium levels following a course of radiation therapy. The patient remains asymptomatic 15 months following radiotherapy despite a gradual return of elevated serum calcium levels.Discussion. Radiation therapy should be considered as a palliative option for patients who are not surgical candidates presenting with medically refractory hypercalcemia.

Entities:  

Year:  1999        PMID: 18521262      PMCID: PMC2395408          DOI: 10.1080/13577149977848

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  15 in total

Review 1.  Malignant ameloblastoma with pulmonary metastasis and hypercalcemia. Report of an autopsy case and review of the literature.

Authors:  N Inoue; M Shimojyo; H Iwai; H Ohtsuki; R Yasumizu; M Shintaku; N Taniguchi; M Inada; T Arika; S Morita
Journal:  Am J Clin Pathol       Date:  1988-10       Impact factor: 2.493

2.  Parathyroid-hormone-related-protein-producing thymic carcinoma presenting as a giant extrathoracic mass.

Authors:  K Suzuki; H Tanaka; T Shibusa; Y Shibuya; M Inuzuka; T Fujishima; S Abe
Journal:  Respiration       Date:  1998       Impact factor: 3.580

3.  An unusual case of adamantinoma of long bones.

Authors:  M Altmannsberger; H Poppe; A Schauer
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

4.  Adamantinoma of the appendicular skeleton--updated.

Authors:  N F Moon; H Mori
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

5.  Hypercalcemia associated with neuroblastoma.

Authors:  R A Al-Rashid; C Cress
Journal:  Am J Dis Child       Date:  1979-08

6.  Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior.

Authors:  H M Hazelbag; A H Taminiau; G J Fleuren; P C Hogendoorn
Journal:  J Bone Joint Surg Am       Date:  1994-10       Impact factor: 5.284

7.  The treatment of ameloblastoma based on pathologic and anatomic principles.

Authors:  D G Gardner; A M Pecak
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

8.  Ameloblastoma of the maxilla with distant metastases and hypercalcemia.

Authors:  G Madiedo; H Choi; J G Kleinman
Journal:  Am J Clin Pathol       Date:  1981-04       Impact factor: 2.493

9.  Hypercalcemia secondary to a pseudoparathormone-secreting ameloblastoma.

Authors:  W F McGuirt; M S Scruggs; J A Koufman
Journal:  Arch Otolaryngol       Date:  1981-08

10.  Adamantinoma of long bones. A histopathological and immunohistochemical study of 23 cases.

Authors:  G Jundt; K Remberger; A Roessner; A Schulz; K Bohndorf
Journal:  Pathol Res Pract       Date:  1995-03       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.